Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens
CRISPR-Cas9 screens are powerful high-throughput tools but can be confounded by nuclease toxicity. Here the authors design a library of variable length gRNAs with thousands of negative controls, including the targeting of ‘safe’ loci to account for on-target site DNA damage toxicity.
Guardado en:
Autores principales: | David W. Morgens, Michael Wainberg, Evan A. Boyle, Oana Ursu, Carlos L. Araya, C. Kimberly Tsui, Michael S. Haney, Gaelen T. Hess, Kyuho Han, Edwin E. Jeng, Amy Li, Michael P. Snyder, William J. Greenleaf, Anshul Kundaje, Michael C. Bassik |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da97c345b50241ee96636d0cb1d3e3fc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements
por: Josh Tycko, et al.
Publicado: (2019) -
Roadmap for the use of base editors to decipher drug mechanism of action.
por: Estel Aparicio-Prat, et al.
Publicado: (2021) -
Lipid hydrolysis monitoring in wastewater treatment: proof-of-concept for a high throughput vegetable oil emulsion based assay
por: P. Van Gaelen, et al.
Publicado: (2021) -
The capital flight quadrilemma: Democratic trade-offs and international investment
por: Michael Bennett
Publicado: (2021) -
An engineered transcriptional reporter of protein localization identifies regulators of mitochondrial and ER membrane protein trafficking in high-throughput CRISPRi screens
por: Robert Coukos, et al.
Publicado: (2021)